EPS taps CluePoints for trial management solution

By Jenni Spinner contact

- Last updated on GMT

(Image: Getty/bestbrk)
(Image: Getty/bestbrk)

Related tags: Clinical trial, CluePoints, Risk management

The Japanese pharma development firm will harness risk-based quality management solutions to help sponsors improve trial quality and safety.

CluePoints, which specializes in providing risk-based study execution (RBx) and data quality oversite software for trial clients, has agreed to provide risk-based quality management (RBQM solutions to EPS sponsors. The aim of the implementation is to help drive early risk detection, improve quality and increase patient safety, cost-effectively and resource-efficiently.

Best practices

According to CluePoints, clinical research and pharmaceutical professionals are increasingly interested in using RBQM to boost efficiently and quality. Furthermore, the technology is designed to enable sponsors and CROS to comply with regulatory mandates, such as European Medicines Agency (EMA) rules around good clinical practice.

Patrick Hughes, chief commercial officer for CluePoints, told Outsourcing-Pharma that RBQM enables study managers to improve quality of studies from start to finish.

Risk management underpins the overall quality of the trial by identifying, controlling and communicating​,” he said. “RBQM encompasses all elements of the study, from planning right through to execution​.”

Hughes added the EMA’s ICH E6 (R2) spells out what the optimal RBQM system should include:

  • Critical process and data identification
  • Risk identification
  • Risk evaluation
  • Risk control
  • Risk communication
  • Risk review
  • Risk reporting

Critical components

Hughes explained the CluePoints solution was designed to tackle each element within the guidance, empowering sponsors and CROs to address each key component.

The CluePoints Risk Assessment solution allows users to quickly and easily collaborate to identify critical process and data and evaluate both the risks themselves and the controls required to mitigate the risks throughout the study,​” he said. “This allows full documentation and audit trails and is designed to be revisited at regular intervals throughout the study​.”

Additionally, Hughes explained, users can uncover inherent risks using different elements within the portfolio. This is made possible through CluePoints proprietary statistical algorithms.

The CluePoints approach incorporates Central Statistical Monitoring (CSM), an unsupervised, independent and objective analysis of clinical and operational data. Organizations in Europe and North American have been adopting the approach to identify risks early on, and EPS plans to adopt CSM with its clients (largely in Japan) and elsewhere.

Tools designed into the central monitoring platform include risk assessment, key risk indicators, data surveillance, patient profiles and more. Clients are able to choose modules that fit their particular needs to implement RBQM in their operations.

Related news

Show more

Related products

show more

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Covance Touchless Drug and Device Vigilance Vision

Covance Touchless Drug and Device Vigilance Vision

Covance Patient Safety | 01-Sep-2020 | Data Sheet

Automation tools enable organizations to identify patterns in structured and unstructured data and facilitate automation of the entire product vigilance...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us

Products

View more

Webinars